Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Avian Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Avian Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Avian Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 105 pages

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY B-Cell Acute Lymphocytic Leukemia (B-Ce...

May 2022 191 pages

B-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY B-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 135 pages

B Cell Lymphoma 2 (Bcl 2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B Cell Lymphoma 2 (Bcl 2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY B Cell Lymphoma 2 (Bcl 2) Drugs in Development by Therapy Areas...

May 2022 99 pages

B Cell Lymphoma-Leukemia 11A (B Cell CLL-Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B Cell Lymphoma-Leukemia 11A (B Cell CLL-Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) Drugs in Development...

May 2022 36 pages

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) Drugs in Development by Therapy Areas and Indications, Stages, MoA,...

May 2022 38 pages

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY B2 Bradykinin Receptor (BK2 Receptor or B...

May 2022 35 pages

Bacillary Dysentery (Shigellosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacillary Dysentery (Shigellosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacillary Dysentery (Shigellosis) Drugs in Development by Stages, Target, MoA,...

May 2022 54 pages

Bacillus Anthracis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacillus Anthracis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacillus Anthracis Infections Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 71 pages

Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 84 pages

Bacteremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bacteremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacteremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 213 pages

Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 37 pages

Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 134 pages

Bacterial Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacterial Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacterial Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 44 pages

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 52 pages

Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 36 pages

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Deve...

May 2022 61 pages

Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 81 pages

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 1 Adrenergic Receptor (B...

May 2022 70 pages

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 2 Adrenergic Receptor (B...

May 2022 97 pages

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 3 Adrenergic Receptor (B...

May 2022 41 pages

Beta Adrenergic Receptor (ADRB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Beta Adrenergic Receptor (ADRB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Adrenergic Receptor (ADRB) Drugs in Development by T...

May 2022 131 pages

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 41 pages

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Glucuron...

May 2022 36 pages

Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indicat...

May 2022 38 pages

Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 52 pages

Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target,...

May 2022 75 pages

Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA...

May 2022 266 pages

Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 36 pages

Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 45 pages

Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 263 pages

Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 61 pages

Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 43 pages

Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 236 pages

Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Born Small For Gestational Age (SGA) Drugs in Development by Stages, Target...

May 2022 35 pages

Brachyury Protein (Protein T or T) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Brachyury Protein (Protein T or T) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Brachyury Protein (Protein T or T) Drugs in Developmen...

May 2022 36 pages

Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 161 pages

Brain Derived Neurotrophic Factor (Abrineurin or BDNF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Brain Derived Neurotrophic Factor (Abrineurin or BDNF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Derived Neurotrophic Factor...

May 2022 43 pages

Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain (Head) Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 35 pages

Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 50 pages

Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Brain Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 119 pages

Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 39 pages

Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Burkholderia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 45 pages

Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Burkitt Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 94 pages

C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMM...

May 2022 40 pages

C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMAR...

May 2022 35 pages

Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 51 pages

Calcineurin (Protein Serine-Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcineurin (Protein Serine-Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMM...

May 2022 75 pages

Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Calcium Activa...

May 2022 52 pages

Calcium Activated Potassium Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Calcium Activated Potassium Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Calcium Activated Potassium Channel Drugs in Developm...

May 2022 51 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...